AKR.L Share News (AKR)

LONDON (Dow Jones)--Akers Biosciences, Inc. (AKR.LN), a designer and manufacturer of rapid diagnostic screening and testing products, Wednesday announces the start of production of a BreathScan alcohol detection product line extension designed for forensic use in law enforcement and other applicable markets. MAIN FACTS: -The System will be branded under the trade name BreathScan PRO and will allow users to determine a subject's breath alcohol level within the range of 0.00% to 0.15%. -Initially, the system will be marketed worldwide for forensic use by trained professionals, including those in civil and military law enforcement, human resources, educational supervision and other safety-related occupations. -User studies are underway to support the Company's application for 510(k) clearance by the U.S. Food and Drug Administration. -ABI will seek an Over-the-Counter designation which would further expand the user base of the product in the United States. -ABI will be opening pre-sale of the BreathScan PRO system to its existing distribution network immediately and anticipates that the delivery of the product will commence in September 2010. -Product launch to new distributors worldwide will begin early 4Q 2010. -Shares closed Tuesday at 10.25 pence. -By Iain Packham, Dow Jones Newswires; 44-20-7842-9269; iain.packham@dowjones.com (END) Dow Jones Newswires June 09, 2010 03:01 ET (07:01 GMT)